(RTTNews) – Lakewood-Amedex Biotherapeutics Inc. (LABT), a clinical-stage biotechnology company, announced progress in manufacturing and formulation for its lead investigational drug candidate, Nu-3, being developed to treat infected diabetic foot ulcers.